Will Arena Pharmaceuticals Inc. (NASDAQ:ARNA) continue to fall, Alpha Natural Resources, Inc. (NYSE:ANR)

Posted by Chris Bell May 6, 2013 0 Comment 2127 views


Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded down 9.16% on last day of the week, and closed at $7.63. The stock traded in the band of $7.50 and $7.81 and the range for the 52-week is $2.52 and $13.50. The share’s 50-day moving average is currently $8.17 and currently the stock is 6.67% below its 50-days moving average reflecting a negative sentiment amongst the investors. The market capitalization of the company is $1.66 billion, and has a negative EPS of -$0.47. The analysts are expecting a price of $9.21 for the share and are forecasting a negative growth of 100.00% in the EPS of the company over the coming year. The moving average 200 days is trading above the moving average of 50 days further reflecting a bearish sign for the stock. The RELATIVE STRENGTH INDEX of the stock is 39.16 reflecting a further space for downside before it enters into an oversold region and thereafter get a support at some key levels to then bounce back. In order to give a gain the stock needs to get above all the key short term averages.

The company reported a loss in the first quarter of $0.09 per share as compared to a loss of $0.18 per share in the previous year. The company announced that the withdrawal of the BELVIQ Marketing Authorization Application has been notified to the European Medicines Agency.

Alpha Natural Resources, Inc. (NYSE:ANR) traded flat on last day of the week, and closed at $7.13. The stock traded in the band of $7.05 and $7.33 and the range for the 52-week is $5.28 and $14.80. The share’s 50-day moving average is currently $7.81 and currently the stock is 9.13% below its 50-days moving average reflecting a negative sentiment amongst the investors. The market capitalization of the company is $1.57 billion, and has a negative EPS of -$11.06. The analysts are expecting a price of $10.80 for the share and are forecasting a positive growth of 35.60% in the EPS of the company over the coming year. The moving average 200 days is trading above the moving average of 50 days further reflecting a bearish sign for the stock. The RELATIVE STRENGTH INDEX of the stock is 43.41 reflecting a further space for downside before it enters into an oversold region and thereafter get a support at some key levels to then bounce back. In order to give a gain the stock needs to get above all the key short term averages.

Deutsche Bank decreased their price target from $10.00 to $9.00 and has a “hold” rating on the stock. Cowen believes that the shares will rise on the lowered cost guidance laid down by the company. Cowen has rated the stock as “Buy” and is targeting a price of $12.


About Chris Bell

Chris Bell is an investing reporter for GDP Insider. Chris covers financial markets and Wall Street, concentrating on developments affecting individual investors and their portfolios. Chris is also over consumer reporter and covers a wide variety of issues ranging from housing to immigration to urban poverty. Chris graduated from the University of Scranton with a degree in Communication and Philosophy. Chris's diligent investigations earned him the honor of being named "Best Reporter" once by the Headliners Foundation of Texas and once by the Houston Press Club.

View all post by Chris Bell Visit author's website

Write Your Comment